Profiel
Shu-Tung Li is the founder of Collagen Matrix, Inc. (founded in 1997) and ReGen Biologics, Inc. (founded in 1987).
At Collagen Matrix, he held the titles of President & Chief Executive Officer from 2011 to 2015.
At ReGen Biologics, he held the title of Director, EVP-Research & Development from 1987 to 2011.
Dr. Li's former jobs include Director-Implants Development at Meadox Medicals, Inc., Vice President-Research & Development at Integra LifeSciences Holdings Corp., Vice President-Research & Development at CollaTech, Inc., and Assistant Professor at the University of Connecticut Health Center.
Dr. Li earned a doctorate degree from the University of Connecticut.
Eerdere bekende functies van Shu-Tung Li
| Bedrijven | Functie | Einde |
|---|---|---|
Collagen Matrix, Inc.
 Collagen Matrix, Inc. Medical SpecialtiesHealth Technology Collagen Matrix, Inc. design and manufactures extracellular matrices for tissue and organ repair and regeneration. The firm offers collagen and mineral-based finished medical devices in the areas of orthopedic-spine surgery, neurosurgery, oral surgery, and wound care. It provides DuraMatrix, Neuroflex, NeuroMatrix, OssiMend, and the Matrix Collagen. The company was founded by Shu-Tung Li in 1997 and is headquartered in Oakland, NJ. | Algemeen Directeur | 23-09-2015 |
University of Connecticut Health Center
 University of Connecticut Health Center Other Consumer ServicesConsumer Services University of Connecticut Health Center provides healthcare services. It is an organization, which composed of the school of medicine, John Dempsey hospital, the UConn medical group & health partners, and university dentists. It offers services for cardiovascular, cancer, behavioral, ambulatory, and neonatal intensive-care. The company was founded in 1961 and is headquartered in Farmington, CT. | Corporate Officer/Principal | - |
Meadox Medicals, Inc.
 Meadox Medicals, Inc. Medical SpecialtiesHealth Technology Part of Boston Scientific Corp., Meadox Medicals, Inc. makes vascular replacement devices. The company is based in Oakland, NJ. Meadox Medicals was acquired by Boston Scientific Corp. on November 20, 1995 for $425 million. | Corporate Officer/Principal | - |
| INTEGRA LIFESCIENCES HOLDINGS CORPORATION | Hoofd Techniek/Wetenschap/O&O | - |
CollaTech, Inc.
 CollaTech, Inc. Packaged SoftwareTechnology Services CollaTech, Inc. produces electronic commerce software. The private company is based in Champaign, IL and has subsidiaries in the United States. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Shu-Tung Li
| University of Connecticut | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| REGEN BIOLOGICS INC. | Health Services |
| INTEGRA LIFESCIENCES HOLDINGS CORPORATION | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Collagen Matrix, Inc.
Collagen Matrix, Inc. Medical SpecialtiesHealth Technology Collagen Matrix, Inc. design and manufactures extracellular matrices for tissue and organ repair and regeneration. The firm offers collagen and mineral-based finished medical devices in the areas of orthopedic-spine surgery, neurosurgery, oral surgery, and wound care. It provides DuraMatrix, Neuroflex, NeuroMatrix, OssiMend, and the Matrix Collagen. The company was founded by Shu-Tung Li in 1997 and is headquartered in Oakland, NJ. | Health Technology |
CollaTech, Inc.
CollaTech, Inc. Packaged SoftwareTechnology Services CollaTech, Inc. produces electronic commerce software. The private company is based in Champaign, IL and has subsidiaries in the United States. | Technology Services |
Meadox Medicals, Inc.
Meadox Medicals, Inc. Medical SpecialtiesHealth Technology Part of Boston Scientific Corp., Meadox Medicals, Inc. makes vascular replacement devices. The company is based in Oakland, NJ. Meadox Medicals was acquired by Boston Scientific Corp. on November 20, 1995 for $425 million. | Health Technology |
